One of the largest and most distinguished programs in the country, the Division of Hematology/Oncology/Stem Cell Transplantation at New York-Presbyterian Morgan Stanley Children's Hospital cares for over 1,500 children and adolescents with cancer and blood disorders each year. Patients are cared for in a dedicated family-centered setting by a multidisciplinary team of physicians, nurses, nurse practitioners, pain specialists, complementary medicine practitioners, psychologists, social workers, and child-life specialists. Outpatient services are provided at the Herbert Irving Child and Adolescent Center, and inpatient care at the New York-Presbyterian Morgan Stanley Children’s Hospital. We also provide outpatient hematology services at off-site locations in Manhattan, the Bronx, Westchester County and New Jersey.
Tradition of Excellence
As one of the earliest programs in the country, the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation has grown to be one of the largest and most distinguished programs serving as a referral center for patients across the United States and abroad.
As a charter member of the Children's Oncology Group (COG), the nation's largest consortium of medical centers for the study of childhood cancer therapy, we are able to offer our patients access to innovative new therapies, including the latest chemotherapy and/or radiation oncology regimens, bone marrow transplant treatments, immunotherapies, and new targeted therapies. The Hospital is one of only 21 institutions in the country designated by the National Cancer Institute through COG to conduct Phase 1 pediatric clinical trials, enabling pediatric patients to take part in potentially breakthrough therapies.
The Division has a long tradition of excellence in the care of children with blood disorders, including inherited and acquired forms of anemia, bleeding and clotting abnormalities, white blood cell disorders and bone marrow failure. The St. Giles Comprehensive Sickle Cell and Thalassemia Program provides comprehensive, family-centered care for pediatric patients with sickle cell disease and thalassemia. The Program is focused on guaranteeing consistent provision of the best evidence-based treatments, assuring early recognition of risks of preventable complications and providing dependable support for effective family and patient self-management. Our program provides pediatric hematology services to the communities of Harlem, Northern Manhattan, and the tri-state area, including newborn screening, stroke prevention, chronic transfusion and iron-chelating therapy, pain management, community outreach and patient education programs.
With one of the largest stem cell transplantation programs in the nation, NewYork-Presbyterian Morgan Stanley Children's Hospital offers stem cell transplantations to treat children and adolescents with certain cancers and non-cancerous conditions, and is renowned for its pioneering work and expertise transplantation for sickle cell disease. The stem cell transplant program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), and National Marrow Donor Program (NMDP) for autologous, allogeneic, and umbilical cord blood transplantations.
The Division is committed to providing personalized high quality, comprehensive care for children and adolescents with cancer and hematologic disorders; to promote disocvery in clinical, translational, and basic biomedical research; and to foster academic experience, education and training.
Conditions We Treat
Our team of specialists provide expert care for a wide range of cancers and blood disorders including:
- Sickle cell disorders
- Other inherited anemia (Diamond-Blackfan, Fanconi)
- Iron deficiency and other nutritional anemia
- Hemolytic anemia
- Aplastic anemia and bone marrow failure syndromes
- Iron overload
- Thrombosis (clotting disorders)
- Bleeding disorders
- von Willebrand disease
- Idiopathic thrombocytopenic purpura (ITP)
- Vascular anomalies
- Primary immunodeficiencies
- Leukemia and lymphomas
- Solid tumors and sarcomas
- Brain tumors
- Autologous stem cell transplantation
- Allogeneic stem cell transplantation